|
Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol JC, Lu L, Alvarez-Fischer D, Carrillo-de Sauvage MA, Saurini F, Coussieu C, Kinugawa K, Prigent A, Höglinger G, Hamon M, Tronche F, Hirsch EC, Vyas S. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6632-7. doi: 10.1073/pnas.1017820108. Epub 2011 Apr 5. PubMed PMID: 21467220; PubMed Central PMCID: PMC3080980.
AÑO: 2011; IF: 9.681
|
21467220
|
Zinger A, Barcia C, Herrero MT, Guillemin GJ. The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease. Parkinsons Dis. 2011;2011:716859. doi: 10.4061/2011/716859. Epub 2011 Jun 3. PubMed PMID: 21687761; PubMed Central PMCID: PMC3109408.
AÑO: 2011
|
|
Heman P, Barcia C, Gómez A, Ros CM, Ros-Bernal F, Yuste JE, de Pablos V, Fernandez-Villalba E, Toledo-Cárdenas MR, Herrero MT. Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys. Histol Histopathol. 2012 Jan;27(1):89-94. PubMed PMID: 22127600.
AÑO: 2012; IF: 2.281
|
|
Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol. 2011 Dec 22;2:82. doi: 10.3389/fneur.2011.00082. eCollection 2011. PubMed PMID: 22203816; PubMed Central PMCID: PMC3244758.
AÑO: 2011
|
|
Barcia C, Ros CM, Annese V, Gómez A, Ros-Bernal F, Aguado-Llera D, Martínez-Pagán ME, de Pablos V, Fernandez-Villalba E, Herrero MT. IFN-? signaling, with the synergistic contribution of TNF-?, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis. 2012 Aug 23;3:e379. doi: 10.1038/cddis.2012.123. PubMed PMID: 22914327; PubMed Central PMCID: PMC3434670.
AÑO: 2012; IF: 6.044
|